FCGR3A and breast cancer: Although polymorphisms, such as FCGR3A-V158F, have been extensively studied14, an overview of FCGR3A-V158F polymorphisms within the Egyptian population is lacking and the association of this polymorphism with trastuzumab benefit for patients with breast cancer is not clear.